NCT00374296 2015-07-01MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory DiseaseMirati Therapeutics Inc.Phase 2 Terminated35 enrolled
NCT00324194 2015-01-08A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic SyndromesMirati Therapeutics Inc.Phase 1 Completed25 enrolled